alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 134 Received in Senate (RDS)]

  2d Session
H. J. RES. 134

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

             October 12 (legislative day, October 2), 1998

                                Received

_______________________________________________________________________

                            JOINT RESOLUTION

 
Making further continuing appropriations for the fiscal year 1999, and 
                          for other purposes.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That section 106(c) of Public 
Law 105-240 is further 
amended by striking ``October 12, 1998'' and inserting in lieu thereof 
``October 14, 1998''.

            Passed the House of Representatives October 12, 1998.

            Attest:

                                                ROBIN H. CARLE,

                                                                 Clerk.
```
#### Angela CLEMENTE, Appellant v. FEDERAL BUREAU OF INVESTIGATION, et al., Appellees

No. 16-5067

September Term, 2017

United States Court of Appeals, District of Columbia Circuit.

Filed On: March 9, 2018

l:08-cv-01252-BJR

James H. Lesar, I, Attorney, Law Office of James Lesar, Silver Spring, MD, for Plaintiff-Appellant

*3R. Craig Lawrence, U.S. Attorney’s Office, (USA) Civil Division, Washington, DC, Daniel Schaefer, Assistant U.S. Attorney, U.S. Attorney’s Office, (USA) Appellate Division, Washington, DC, for Defendants-Appellees

BEFORE: Garland, Chief Judge; Henderson, Rogers, Tatel, Griffith, Kavanaugh *, Srinivasan, Millett, Pillard, Wilkins, and Katsas, Circuit Judges; Edwards, Senior Circuit Judge'

*

 A separate statement by Circuit Judge Kava-naugh, concurring in the denial of rehearing en banc, is attached.

ORDER

Per Curiam

Upon consideration of appellant’s petition for rehearing en banc and the response thereto; appellant’s motion for leave to reply; and the absence of a re"quest by any member of the court for a vote on the petition, it is

ORDERED that the motion for leave be denied. It is

FURTHER ORDERED that the petition be denied.

Kavanaugh, Circuit Judge, concurring in the denial of rehearing en bane:

As explained in my separate opinion in Morley v. CIA, 719 F.3d 689 (D.C. Cir. 2013), this Court’s four-factor test for awarding attorney’s fees in FOIA cases is inconsistent with FOIA’s text and structure, and impermissibly favors some FOIA plaintiffs over other equally deserving FOIA plaintiffs. In an appropriate case, I believe that the en banc Court should reexamine and jettison that four-factor test. But for reasons explained by the Government in its response to the petition for rehearing en banc, this case is not an appropriate vehicle for such reconsideration.
No. 11-1101.

#### Timberridge Presbyterian Church, Inc., et al. *v.*Presbytery of Greater Atlanta, Inc.

Sup. Ct. Ga. Certiorari denied.
# Official Journal C 184/27 J

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 184 |
| | |
| English edition | Information and Notices | Volume 4827 July 2005 |

ISSN 1725-2423

Official Journal

of the European Union

C 184

English edition

Information and Notices

Volume 4827 July 2005

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Commission |
| 2005/C 184/1 | Euro exchange rates | 1 |
| 2005/C 184/2 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 2204/2002 of 12 December 2002 on the application of Articles 87 and 88 of the EC Treaty to State aid for employment (1) | 2 |

Notice No

Contents

page

I   Information

Commission

2005/C 184/1

Euro exchange rates

1

2005/C 184/2

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 2204/2002 of 12 December 2002 on the application of Articles 87 and 88 of the EC Treaty to State aid for employment (1)

2

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN
February 6, 2013

MEMORANDUM

From: William H. Maxwell EPA/SPPD/ESG (D243-01)

To: Docket Number EPA-HQ-OAR-2009-0234

Subject: Meeting with American Public Power Asso ciation (APPA) and Tr iState Generation

Attendees :

Janet McCabe, EPA Teresa Pugh, American P ublic Power Association Barbara Walz, TriState Generati on and Transmission Association

Discussion :

A general discussion was held regarding clarifying questions on the proposed Mercury and Air Toxics Standards (MATS) reconsideration issues.
<PAGE>



                                                                   EXHIBIT 31.1

 CERTIFICATION PURSUANT TO RULE 15d-14(a) (17 CFR 240.15d-14(a)) AND SECTION 302
                        OF THE SARBANES-OXLEY ACT OF 2002



I, John F. Kennedy, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of ChrisKen Partners
Cash Income Fund L.P., a Delaware limited partnership;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(c) and 15d-15 (e) for the registrant and have:

a) designed such disclosure controls and procedures or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared; and
b) evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report are conclusions about the effectiveness
of the disclosure controls and procedures as of the end of the period covered by
this report based on such evaluation, and;
c) disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting.

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or
operation of internal controls over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information, and;
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.



Date: May 17, 2004

/s/John F. Kennedy
------------------
John F. Kennedy
President
ChrisKen Income Properties, Inc.,
     Managing General Partner
ChrisKen Partners Cash Income Fund L.P.
(logo) pwc

 

 

**Report of Independent RegisteredPublic Accounting Firm**

 

To the Board of Directors, PNCFinancial Services Group, Inc.:

 

We have examinedmanagement’s assertion, included in the accompanying Report on Assessmentof Compliance with Regulation AB Servicing Criteria, that Midland LoanServices, a division of PNC Bank, National Association (“Midland”or the “Company”) complied with the servicing criteria set forth inItem 1122(d) of the Securities and Exchange Commission's Regulation AB for alltransactions serviced on the *Enterprise!* Loan Management System (the“Platform”), as of December 31, 2016 and for the year then ended,excluding criteria 1122(d)(1)(iii), 1122(d)(3)(i)(B), 1122(d)(3)(i)(C),1122(d)(3)(i)(D), 1122(d)(3)(ii), 1122(d)(3)(iii), 1122(d)(3)(iv), and1122(d)(4)(xv), which the Company has determined are not applicable to theservicing activities performed by it with respect to the Platform. Managementis responsible for the Company's compliance with the servicing criteria. Ourresponsibility is to express an opinion on management's assertion based on ourexamination.

 

Our examination was conductedin accordance with attestation standards of the Public Company AccountingOversight Board (United States) and, accordingly, included examining, on a testbasis, evidence about the Company’s compliance with the applicableservicing criteria and performing such other procedures as we considerednecessary in the circumstances. Our examination included testing of selectedasset-backed transactions and securities that comprise the Platform, testing ofselected servicing activities related to the Platform, and determining whetherthe Company processed those selected transactions and performed those selectedactivities in compliance with the applicable servicing criteria. Our procedureswere limited to the selected transactions and servicing activities performed bythe Company during the period covered by this report. Our procedures were notdesigned to detect noncompliance arising from errors that may have occurredprior to or subsequent to our tests that may have affected the balances oramounts calculated or reported by the Company during the period covered by thisreport. We believe that our examination provides a reasonable basis for ouropinion. Our examination does not provide a legal determination on theCompany’s compliance with the servicing criteria.

 

In our opinion,management’s assertion that Midland complied with the aforementionedapplicable servicing criteria as of and for the year ended December 31, 2016for the Platform is fairly stated, in all material respects.

 

 

/s/ PricewaterhouseCoopers LLP

 

February 17, 2017

 

 

*PricewaterhouseCoopers LLP,1100 Walnut Street, Suite 1300, Kansas City, MO 64106*

*T: (816) 472 7921, F: (816)218 1890 www.pwc.com/us*

* *
#### NEIFERT, G. v. SPEEDWAY LLC and Tracey R. Correll

1891 MDA 2016

Superior Court of Pennsylvania.

9/14/2017

15-3929

(Berks)

Affirmed
<PAGE>
 
                                                                   EXHIBIT 23.1
 
                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
 
  As independent public accountants, we hereby consent to the use of our
report and to all other references to our Firm included in or made a part of
this registration statement.
 
                                          ARTHUR ANDERSEN LLP
 
Houston, Texas
May 21, 1997
## MEMORANDUM

**DATE:** 11/24/14 **FROM:** Ken Mitchell/EPA Region 4 **TO:** Clean Power Plan for Existing Power Plants; Docket Id: OAR – 2013
- 0602 **SUBJECT:** Discussion of the Clean Power Plan at the Carolinas Air Pollution Control Association Fall

Meeting
**SUMMARY :**  

### The Office of Air Quality Planning and Standards provided information on the Clean Power Plan to participants at Carolinas Air Pollution Control Association Fall Meeting 

### in Myrtle Beach, SC , on October 1 6 , 2014 . The Clea n Power Plan for Existing Power Plants was p roposed on June 2, 2014. **ATTENDEES :**  **EPA** Lisa Conner/EPA OAQPS **External Stakeholders** Tom Effinger/SCANA Corporation Tom Lorenzen/Dorsey & Whitney LLP Don van der Vaart/NC DENR Bill Lane / Kilpatrick Townsend & Stockton Approximately 150 other attendees
**ATTACHMENT**
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8322 Introduced in House (IH)]

<DOC>

116th CONGRESS
  2d Session
                                H. R. 8322

 To amend title XI of the Social Security Act to provide the Secretary 
 of Health and Human Services with the authority to temporarily modify 
certain Medicare requirements for hospice care during the COVID public 
                           health emergency.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 21, 2020

 Mr. Balderson (for himself and Ms. Shalala) introduced the following 
  bill; which was referred to the Committee on Ways and Means, and in 
 addition to the Committee on Energy and Commerce, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL

 
 To amend title XI of the Social Security Act to provide the Secretary 
 of Health and Human Services with the authority to temporarily modify 
certain Medicare requirements for hospice care during the COVID public 
                           health emergency.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``COVID-19 Hospice Respite Care Relief 
Act of 2020''.

SEC. 2. SECRETARIAL AUTHORITY TO TEMPORARILY MODIFY CERTAIN MEDICARE 
              REQUIREMENTS FOR HOSPICE CARE DURING THE COVID PUBLIC 
              HEALTH EMERGENCY.

    (a) Authority.--The first sentence of section 1135(b) of the Social 
Security Act (42 U.S.C. 1320b-5(b)) is amended--
            (1) in paragraph (7), by striking ``and'' at the end;
            (2) in paragraph (8), by striking the period at the end and 
        inserting ``; and''; and
            (3) by inserting after paragraph (8) the following new 
        paragraph:
            ``(9) the limitations under section 1861(dd)(1)(G) that 
        respite care--
                    ``(A) may only be provided in an inpatient setting; 
                and
                    ``(B) may not be provided consecutively for more 
                than five days (except that the Secretary may not 
                increase the number of consecutive days to more than 15 
                days).''.
    (b) Emergency Period.--Section 1135(g)(1)(B) of the Social Security 
Act (42 U.S.C. 1320b-5(g)(1)(B)) is amended, in the matter preceding 
clause (i), by striking ``subsection (b)(8)'' and inserting 
``paragraphs (8) and (9) of subsection (b)''.
    (c) Implementation.--Notwithstanding any other provision of law, 
the Secretary of Health and Human Services may implement the amendments 
made by this section by interim final rule, program instruction, or 
otherwise.
                                 <all>
```
#### CF CRESPE LLC, Appellant v. SILICON LABORATORIES INC., Appellee

2017-1072

United States Court of Appeals, Federal Circuit.

December 7, 2017

Craig Robert Smith, Lando & Anastasi, LLP, Cambridge, MA, argued for appellant. Also represented by Eric P. Carne. VALE.

Peter J. Ayers, Law Office of Peter J. Ayers, Austin, TX, argued for appellee.

(Dyk, Schall, and Reyna, Circuit Judges).

*1001JUDGMENT

Per Curiam

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. *See*Fed. Cir. R. 36.
# Biology Threat Reduction Program Nigeria Factsheet

/ Published April 14, 2023
<PAGE>

                                                                    EXHIBIT 23.2
                                                                    ------------


                               CONSENT OF COUNSEL
                               ------------------


                                (See Exhibit 5)
IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

JERRY RANSOME,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 300 EAL 2016

Petition for Allowance of Appeal from

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 29th day of November, 2016

, the Petition for Allowance of

Appeal is DENIED

.
EX-10.2



 Exhibit 10.2 

AMENDMENT NO. 1 
 TO 

AMENDED AND RESTATED 
 ALLIANCE
PARTNERS PROGRAM AGREEMENT 
 This Amendment No. 1 to Amended and Restated Alliance Partners Program Agreement (“Amendment
No. 1”), effective February 19, 2014 (“Effective Date”), is entered into by and between Blackhawk Network, Inc., an Arizona corporation (“Blackhawk”), and Safeway Inc., a
Delaware corporation (“Safeway”). 
 WHEREAS, the parties entered into that certain Amended and Restated Alliance
Partners Program Agreement effective as of December 30, 2012 (the “Agreement”), and wish to amend the Agreement to extend its initial term. 

NOW, THEREFORE, in consideration of the mutual covenants and promises of the Parties and other good and valuable consideration, the
sufficiency and receipt of which is hereby acknowledged, the Parties agree as follows intending to be legally bound: 
  

	1.	Extension of Term. Section 4 of Exhibit A to the Agreement is hereby amended as follows: The date “December 30, 2017” is deleted and replaced by the date “December 30, 2019.”


  

	2.	General. Except as specifically amended by this Amendment No. 1, all terms and provisions of the Agreement shall remain in full force and effect. Any capitalized terms used without definition in this
Amendment No. 1 shall have the meanings ascribed to them in the Agreement. 

  

	3.	Counterparts. This Agreement may be executed in counterparts, which execution may be by facsimile, each of which shall be an original, but all of which shall constitute one, and the same, document.


 IN WITNESS WHEREOF, the undersigned have executed this Amendment No. 1 as of the Effective Date. 

 

			
	BLACKHAWK NETWORK, INC.
		
	By:	 	  /s/ Jerry Ulrich

	Print Name:	 	Jerry Ulrich
	Print Title:	 	Chief Financial & Administrative Officer
	
	SAFEWAY INC.
		
	By:	 	  /s/ Laura A. Donald

	Print Name:	 	Laura A. Donald
	Print Title:	 	Vice President
EX-10.8.4



 Exhibit 10.8.4 
 [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.

 October 24, 2011 
 Timothy C.
Rodell, M.D. 
 President and CEO 

GlobeImmune, Inc. 
 1450 Infinite Dr. 

Louisville CO 80027 
 Sent via Federal Express

 With Email confirmation to: jpbizzari@celgene.com; agrant@celgene.com 
 tperone@celgene.com; ggolumbeski@celgene.com; tcrodell@globeimmune.com; 

kirkc@globeimmune.com 
 Dear Tim:

 This letter and the attached Appendix A (Supplemental
GI-4000-02 Agreement) is to confirm the understanding that Celgene Corporation (Celgene) and GlobeImmune, Inc. (GlobeImmune) have reached regarding additional analyses
involving the existing GI-4000-02 data set. 
 Celgene agrees
with GlobeImmune that with respect to the GI-4000 Drug Candidate, [*] under the Collaboration and Option Agreement by and between GlobeImmune, Inc. and Celgene Corporation entered into May 14, 2009 and
subsequent amendments thereto (hereinafter, “Agreement”). Any term used in this letter that is capitalized, and not defined in this letter, will have the meaning assigned to such term in the Agreement. 

[*] 
 Upon execution of this letter,
Supplemental GI-4000 Agreement begins on the date of this letter. 

  
 Page 1 of 3









 [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED. 
 Except as set forth in this letter
agreement, all provisions of the Agreement shall remain in full force and effect. 
 Please execute this Supplemental GI-4000 Agreement by signing and dating in the spaces below, thereby signifying your consent to the terms and conditions herein. Please return an executed copy to me. 

 



	
	Sincerely,
	
	/s/
	
	 Jean-Pierre Bizzari M.D.

	Name
	
	 SVP and Group Head of Onc./Hematology

	Title
	
	Celgene Corporation

 


			
	Acknowledged and Agreed:
	
	GLOBEIMMUNE, INC.
		
	By:	  	 /s/ Timothy C. Rodell

		
	Name:	  	 Timothy C. Rodell M.D.

		
	Title:	  	 President & Chief Executive Officer

		
	Date:	  	 24 Oct 2011


 
 


  
 Page 2 of 3









 [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED. 
 APPENDIX A —

 [*] 

  
 Page 3 of 3
| (logo) WELLS FARGO | **Corporate Trust Services**

  MAC R1204-010  9062 Old Annapolis Road  Columbia, MD 21045  Tel: 410 884 2000  Fax: 410 715 2380 |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------|

 

 

Morgan Stanley Capital I Inc.

1585 BROADWAY

NEW YORK, New York 10036-8200

 

Re:        Annual Statement of Compliance for Morgan Stanley Bank of America Merrill LynchTrust 2014-C19, Commercial Mortgage Pass-Through Certificates, Series 2014-C19

 

Per the Pooling and ServicingAgreement dated as of December 1, 2014 (the "Agreement"), the undersigned,a duly authorized officer of Wells Fargo Bank, N.A., as CertificateAdministrator ("Wells Fargo"), hereby certifies as follows as of andfor the year ending December 31, 2016 (the "Reporting Period"):

 

(a)         A review of Wells Fargo's activities during the Reporting Period and of itsperformance under the Agreement has been made under such officer's supervision;and

 

(b)         To the best of such officer's knowledge, based on such review, Wells Fargo hasfulfilled all of its obligations under the Agreement in all material respectsthroughout the Reporting Period.

 

 

February 27, 2017

 

  

/s/ Brian Smith

BRIAN SMITH

Vice President

 

 

| Wells Fargo Bank, N.A. | (logo) Together we’ll  go far |
|------------------------|-------------------------------------|